Article History
Received: 1 April 2023
Accepted: 25 July 2023
First Online: 7 August 2023
Declarations
:
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
: No animal studies were carried out by the authors for this article.
: SM serves on the Hypertrophic Cardiomyopathy Advisory Board of Bristol Myers Squibb, and is a Consultant for Tenaya Therapeutics. The remaining authors have nothing to disclose.